Search for "이상지혈증" translated into English medical term, "dyslipidemia"
- Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia
-
Lee J, Lee SH
- KMID: 2547638
- Korean J Intern Med.
- 2023 Nov;38(6):797-809.
- doi: 10.3904/kjim.2023.243
Dyslipidemia is a significant risk factor for atherosclerotic cardiovascular disease (ASCVD), and statins are the primary therapeutic options for reducing low-density lipoprotein cholesterol (LDL-C) levels. However, it can be challenging... -
- CITED
-
- Close
- SHARE
-
- Close
- Lipid variability in patients with diabetes mellitus
-
Lee J, Lee SH
- KMID: 2547303
- Cardiovasc Prev Pharmacother.
- 2023 Oct;5(4):126-133.
- doi: 10.36011/cpp.2023.5.e18
Diabetic dyslipidemia is characterized by hypertriglyceridemia, low high-density lipoprotein cholesterol (HDL-C), elevated low-density lipoprotein cholesterol (LDL-C), and the predominance of small dense LDL particles caused by insulin resistance in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- 2023 Clinical Practice Guidelines for Diabetes: Management of Cardiovascular Risk Factors
-
Yang YS
- KMID: 2546630
- J Korean Diabetes.
- 2023 Sep;24(3):135-140.
- doi: 10.4093/jkd.2023.24.3.135
To prevent cardiovascular disease (CVD), which is one of the ultimate goals in the management of patients with diabetes, it is important to control not only hyperglycemia, but also modifiable... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Dyslipidemia in Patients with Diabetes Mellitus
-
Lee KA
- KMID: 2546627
- J Korean Diabetes.
- 2023 Sep;24(3):111-119.
- doi: 10.4093/jkd.2023.24.3.111
Most patients with diabetes mellitus (DM) have dyslipidemia, which is characterized by increased triglycerides, decreased high-density lipoprotein cholesterol, and increased small dense low-density lipoprotein cholesterol (LDL-C). Dyslipidemia is an important... -
- CITED
-
- Close
- SHARE
-
- Close
- Public Awareness of Dyslipidemia Among the Korean Population: A Survey Study
-
Bae JH, Jin ES, Kim SE, Kang S, Lee JY, Kim M, Jin HY, Shin MJ, Jeong IK, the Committee of Public Relation of the Korean Society of Lipid and Atherosclerosis
- KMID: 2546562
- J Lipid Atheroscler.
- 2023 Sep;12(3):307-314.
- doi: 10.12997/jla.2023.12.3.307
Objective: We aimed to assess the level of public awareness regarding dyslipidemia and its management among the Korean population. Methods: We conducted a web- or mobile-based survey study targeting the general... -
- CITED
-
- Close
- SHARE
-
- Close
- Elevated Lipoprotein(a) Levels and Atrial Fibrillation: A Systematic Review
-
Masson W, Barbagelata L, Nogueira JP, Corral P, Lavalle-Cobo A, Romeo FJ
- KMID: 2546559
- J Lipid Atheroscler.
- 2023 Sep;12(3):267-276.
- doi: 10.12997/jla.2023.12.3.267
Objective: The role of lipoprotein(a) (Lp[a]) as a possibly causal risk factor for atherosclerotic cardiovascular disease has been well established. However, the clinical evidence regarding the association between Lp(a) levels... -
- CITED
-
- Close
- SHARE
-
- Close
- Dyslipidemia Fact Sheet in South Korea, 2022
-
Jin ES, Shim JS, Kim SE, Bae JH, Kang S, Won JC, Shin MJ, Jin HY, Moon J, Lee H, Kim HC, Jeong IK, on Behalf of the Committee of Public Relation of the Korean Society of Lipid and Atherosclerosis
- KMID: 2546122
- Diabetes Metab J.
- 2023 Sep;47(5):632-642.
- doi: 10.4093/dmj.2023.0135
Background: This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name... -
- CITED
-
- Close
- SHARE
-
- Close
- Dyslipidemia Fact Sheet in South Korea, 2022
-
Jin ES, Shim JS, Kim SE, Bae JH, Kang S, Won JC, Shin MJ, Jin HY, Moon J, Lee H, Kim HC, Jeong IK, on behalf of the Committee of Public Relation of the Korean Society of Lipid and Atherosclerosis
- KMID: 2546557
- J Lipid Atheroscler.
- 2023 Sep;12(3):237-251.
- doi: 10.12997/jla.2023.12.3.237
Objective: This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name... -
- CITED
-
- Close
- SHARE
-
- Close
- Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview
-
Suh SH, Kim SW
- KMID: 2546120
- Diabetes Metab J.
- 2023 Sep;47(5):612-629.
- doi: 10.4093/dmj.2023.0067
Dyslipidemia is a potentially modifiable cardiovascular risk factor. Whereas the recommendations for the treatment target of dyslipidemia in the general population are being more and more rigorous, the 2013 Kidney... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between dyslipidemia and asthma in children: a systematic review and multicenter cohort study using a common data model
-
Lim JE, Kim HM, Kim JH, Baek HS, Han MY
- KMID: 2544747
- Clin Exp Pediatr.
- 2023 Aug;66(8):357-365.
- doi: 10.3345/cep.2023.00290
Background: The association between dyslipidemia and asthma in children remains unclear. Purpose: This study investigated the association between dyslipidemia and cholesterol levels in children. Methods: A systematic literature review was performed to... -
- CITED
-
- Close
- SHARE
-
- Close
- The Association between the Local Safety Level Index and Cardiovascular Risk Factors: The Korean National Health and Nutrition Examination Survey, 2016–2018
-
Cho WH, Hwang JS, Yun JM
- KMID: 2543192
- Korean J Fam Pract.
- 2023 Jun;13(2):105-111.
- doi: 10.21215/kjfp.2023.13.2.105
Background: Hypertension, diabetes, and dyslipidemia are the major risk factors for cardio-cerebrovascular disease, and have the highest mortality rates among the major diseases, except for cancers. According to statistics from... -
- CITED
-
- Close
- SHARE
-
- Close
- Identification of subgroups with poor lipid control among patients with dyslipidemia using decision tree analysis: the Korean National Health and Nutrition Examination Survey from 2019 to 2021
-
Kim HS, Jeong SH
- KMID: 2548283
- J Korean Biol Nurs Sci.
- 2023 May;25(2):131-142.
- doi: 10.7586/jkbns.23.0007
Purpose: The aim of this study was to assess lipid levels and to identify groups with poor lipid control group among patients with dyslipidemia. Methods: Data from 1,399 Korean patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
-
Yang YS, Kim HL, Kim SH, Moon MK, on Behalf of Committee of Clinical Practice Guideline, Korean Diabetes Association and Clinical Practice Guideline Committee, Korean Society of Lipid and Atherosclerosis
- KMID: 2538926
- Diabetes Metab J.
- 2023 Jan;47(1):1-9.
- doi: 10.4093/dmj.2022.0448
Dyslipidemia in patients with diabetes is an important treatment target as a modifiable risk factor for cardiovascular disease (CVD). Although the primary treatment goal for dyslipidemia is to control low-density... -
- CITED
-
- Close
- SHARE
-
- Close
- Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
-
Yang YS, Kim HL, Kim SH, Moon MK, on behalf of Committee of Clinical Practice Guideline, Korean Diabetes Association and Clinical Practice Guideline Committee, Korean Society of Lipid and Atherosclerosis
- KMID: 2539210
- J Lipid Atheroscler.
- 2023 Jan;12(1):12-22.
- doi: 10.12997/jla.2023.12.1.12
Dyslipidemia in patients with diabetes is an important treatment target as a modifiable risk factor for cardiovascular disease (CVD). Although the primary treatment goal for dyslipidemia is to control low-density... -
- CITED
-
- Close
- SHARE
-
- Close
- Mulberry (Morus alba L.) ethanol extract attenuates lipid metabolic disturbance and adipokine imbalance in high-fat fed rats
-
Noh Dj, Yoon GA
- KMID: 2536506
- Nutr Res Pract.
- 2022 Dec;16(6):716-728.
- doi: 10.4162/nrp.2022.16.6.716
BACKGROUND/OBJECTIVES: An imbalanced adipokine profile in obesity increases the susceptibility to obesity-related cardiometabolic alterations, including type 2 diabetes, hypertension, dyslipidemia, and non-alcoholic fatty liver disease. The mulberry plant has been... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases
-
Shin HS, Jun BG, Yi SW
- KMID: 2534342
- Clin Mol Hepatol.
- 2022 Oct;28(4):773-789.
- doi: 10.3350/cmh.2021.0383
Despite the increasing prevalence of metabolic disorders, the potential effects of metabolic factors on hepatocellular carcinoma (HCC) development in individuals with chronic liver diseases (CLDs) are not well understood. For... -
- CITED
-
- Close
- SHARE
-
- Close
- Eating Alone and Metabolic Syndrome: A Population-Based Korean National Health and Nutrition Examination Survey 2017-2019
-
Lee J, Hyun M, Suh Y, Kim D, Hong S
- KMID: 2534132
- Korean J Health Promot.
- 2022 Sep;22(3):123-130.
- doi: 10.15384/kjhp.2022.22.3.123
Background: With the increase in the number of single-person households, the number of people eating alone is increasing, and several previous studies have been published that this eating culture affects... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of polystyrene microplastic exposure on lipid profile and oxidative stress status of male and female Wistar rats
-
Nnoruka UC, Okonkwo CJ, Ilechukwu I, Okonkwo CJ, Belonwu DC
- KMID: 2534368
- Environ Anal Health Toxicol.
- 2022 Sep;37(3):e2022024.
- doi: 10.5620/eaht.2022024
Microplastics (MPs) are currently global environmental pollutants, and their associated health risks cannot be ignored. However, research on MP toxicity in mammals is limited. We investigated the effects of polystyrene... -
- CITED
-
- Close
- SHARE
-
- Close
- A New Modality in Dyslipidemia Treatment: Antisense Oligonucleotide Therapy
-
Kim K, Choi SH
- KMID: 2533270
- J Lipid Atheroscler.
- 2022 Sep;11(3):250-261.
- doi: 10.12997/jla.2022.11.3.250
There are unmet needs for pharmacologic agents beyond current medications, such as statins, to effectively lower low-density lipoprotein cholesterol levels to target goals, especially in patients with very high or... -
- CITED
-
- Close
- SHARE
-
- Close
- The Atherogenic Index of Plasma is Associated With Cerebral Small Vessel Disease: A Cross-Sectional Study
-
Nam KW, Kwon HM, Park JH, Kwon H
- KMID: 2533269
- J Lipid Atheroscler.
- 2022 Sep;11(3):262-271.
- doi: 10.12997/jla.2022.11.3.262
Objective: Recently, the lipid profile of atherogenic dyslipidemia has become important in cerebrovascular diseases. Atherogenic index of plasma (AIP), an index that reflects this lipid profile as a single number,... -
- CITED
-
- Close
- SHARE
-
- Close
